Cargando…

Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation

BACKGROUND: Since stroke patients with nonvalvular atrial fibrillation (NVAF) have poor outcomes in general, the prediction of outcomes following discharge is of utmost concern for these patients. We previously reported that brain natriuretic peptide (BNP) levels were significantly higher in NVAF pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Maruyama, Kenji, Uchiyama, Shinichiro, Shiga, Tsuyoshi, Iijima, Mutsumi, Ishizuka, Kentaro, Hoshino, Takao, Kitagawa, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465753/
https://www.ncbi.nlm.nih.gov/pubmed/28253498
http://dx.doi.org/10.1159/000457808
_version_ 1783242994199035904
author Maruyama, Kenji
Uchiyama, Shinichiro
Shiga, Tsuyoshi
Iijima, Mutsumi
Ishizuka, Kentaro
Hoshino, Takao
Kitagawa, Kazuo
author_facet Maruyama, Kenji
Uchiyama, Shinichiro
Shiga, Tsuyoshi
Iijima, Mutsumi
Ishizuka, Kentaro
Hoshino, Takao
Kitagawa, Kazuo
author_sort Maruyama, Kenji
collection PubMed
description BACKGROUND: Since stroke patients with nonvalvular atrial fibrillation (NVAF) have poor outcomes in general, the prediction of outcomes following discharge is of utmost concern for these patients. We previously reported that brain natriuretic peptide (BNP) levels were significantly higher in NVAF patients with larger infarcts, higher modified Rankin Scale (mRS) score, and higher CHADS(2) score. In the present study, we evaluated an array of variables, including BNP, in order to determine significant predictors for functional outcome in patients with NVAF after acute ischemic stroke (AIS). METHODS: A total of 615 consecutive patients with AIS within 48 h of symptom onset, admitted to our hospital between April 2010 and October 2015, were retrospectively searched. Among these patients, we enrolled consecutive patients with NVAF. We evaluated the mRS score 3 months after onset of stroke and investigated associations between mRS score and the following clinical and echocardiographic variables. Categorical variables included male sex, current smoking, alcohol intake, hypertension, diabetes mellitus, dyslipidemia, coronary artery disease, peripheral artery disease, use of antiplatelet drugs, anticoagulants, or tissue plasminogen activator (tPA), and infarct size. Continuous variables included age, systolic blood pressure (SBP), diastolic blood pressure, hemoglobin, creatinine, D-dimer, brain natriuretic peptide (BNP), left atrial diameter, left ventricular ejection fraction (EF), and early mitral inflow velocity/diastolic mitral annular velocity (E/e’). We also analyzed the association of prestroke CHADS(2), CHA(2)DS(2)-VASc, and R(2)CHADS(2) scores, and National Institutes of Health Stroke Scale (NIHSS) score on admission with mRS score 3 months after the onset of stroke. Patients were classified into 2 groups according to mRS score: an mRS score ≤2 was defined as good outcome, an mRS score ≥3 was defined as poor outcome. To clarify the correlations between categorical or continuous variables and mRS score, uni- and multivariate logistic regression models using the stepwise variable selection method were applied. RESULTS: Among 157 patients with NVAF after AIS, 63.7% were male and the mean age was 75.9 years. In univariate regression analysis, poor outcome (mRS score ≥3) was associated with use of tPA, infarct size, age, SBP, BNP, EF, and NIHSS score. In multivariate regression analysis, BNP levels (odds ratio [OR] 6.40; 95% confidence interval [CI] 1.26–32.43; p = 0.0235) and NIHSS score (OR 2.87; 95% CI 1.84–4.47; p < 0.001) were significantly associated with poor outcome (mRS score ≥3) after adjusting for use of tPA, infarct size, age, BNP, EF, and NIHSS score. CONCLUSIONS: Apart from NIHSS score, BNP was a very useful predictor for long-term outcomes of patients with NVAF after AIS.
format Online
Article
Text
id pubmed-5465753
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-54657532017-06-13 Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation Maruyama, Kenji Uchiyama, Shinichiro Shiga, Tsuyoshi Iijima, Mutsumi Ishizuka, Kentaro Hoshino, Takao Kitagawa, Kazuo Cerebrovasc Dis Extra Original Paper BACKGROUND: Since stroke patients with nonvalvular atrial fibrillation (NVAF) have poor outcomes in general, the prediction of outcomes following discharge is of utmost concern for these patients. We previously reported that brain natriuretic peptide (BNP) levels were significantly higher in NVAF patients with larger infarcts, higher modified Rankin Scale (mRS) score, and higher CHADS(2) score. In the present study, we evaluated an array of variables, including BNP, in order to determine significant predictors for functional outcome in patients with NVAF after acute ischemic stroke (AIS). METHODS: A total of 615 consecutive patients with AIS within 48 h of symptom onset, admitted to our hospital between April 2010 and October 2015, were retrospectively searched. Among these patients, we enrolled consecutive patients with NVAF. We evaluated the mRS score 3 months after onset of stroke and investigated associations between mRS score and the following clinical and echocardiographic variables. Categorical variables included male sex, current smoking, alcohol intake, hypertension, diabetes mellitus, dyslipidemia, coronary artery disease, peripheral artery disease, use of antiplatelet drugs, anticoagulants, or tissue plasminogen activator (tPA), and infarct size. Continuous variables included age, systolic blood pressure (SBP), diastolic blood pressure, hemoglobin, creatinine, D-dimer, brain natriuretic peptide (BNP), left atrial diameter, left ventricular ejection fraction (EF), and early mitral inflow velocity/diastolic mitral annular velocity (E/e’). We also analyzed the association of prestroke CHADS(2), CHA(2)DS(2)-VASc, and R(2)CHADS(2) scores, and National Institutes of Health Stroke Scale (NIHSS) score on admission with mRS score 3 months after the onset of stroke. Patients were classified into 2 groups according to mRS score: an mRS score ≤2 was defined as good outcome, an mRS score ≥3 was defined as poor outcome. To clarify the correlations between categorical or continuous variables and mRS score, uni- and multivariate logistic regression models using the stepwise variable selection method were applied. RESULTS: Among 157 patients with NVAF after AIS, 63.7% were male and the mean age was 75.9 years. In univariate regression analysis, poor outcome (mRS score ≥3) was associated with use of tPA, infarct size, age, SBP, BNP, EF, and NIHSS score. In multivariate regression analysis, BNP levels (odds ratio [OR] 6.40; 95% confidence interval [CI] 1.26–32.43; p = 0.0235) and NIHSS score (OR 2.87; 95% CI 1.84–4.47; p < 0.001) were significantly associated with poor outcome (mRS score ≥3) after adjusting for use of tPA, infarct size, age, BNP, EF, and NIHSS score. CONCLUSIONS: Apart from NIHSS score, BNP was a very useful predictor for long-term outcomes of patients with NVAF after AIS. S. Karger AG 2017-03-02 /pmc/articles/PMC5465753/ /pubmed/28253498 http://dx.doi.org/10.1159/000457808 Text en Copyright © 2017 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission.
spellingShingle Original Paper
Maruyama, Kenji
Uchiyama, Shinichiro
Shiga, Tsuyoshi
Iijima, Mutsumi
Ishizuka, Kentaro
Hoshino, Takao
Kitagawa, Kazuo
Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation
title Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation
title_full Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation
title_fullStr Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation
title_full_unstemmed Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation
title_short Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation
title_sort brain natriuretic peptide is a powerful predictor of outcome in stroke patients with atrial fibrillation
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465753/
https://www.ncbi.nlm.nih.gov/pubmed/28253498
http://dx.doi.org/10.1159/000457808
work_keys_str_mv AT maruyamakenji brainnatriureticpeptideisapowerfulpredictorofoutcomeinstrokepatientswithatrialfibrillation
AT uchiyamashinichiro brainnatriureticpeptideisapowerfulpredictorofoutcomeinstrokepatientswithatrialfibrillation
AT shigatsuyoshi brainnatriureticpeptideisapowerfulpredictorofoutcomeinstrokepatientswithatrialfibrillation
AT iijimamutsumi brainnatriureticpeptideisapowerfulpredictorofoutcomeinstrokepatientswithatrialfibrillation
AT ishizukakentaro brainnatriureticpeptideisapowerfulpredictorofoutcomeinstrokepatientswithatrialfibrillation
AT hoshinotakao brainnatriureticpeptideisapowerfulpredictorofoutcomeinstrokepatientswithatrialfibrillation
AT kitagawakazuo brainnatriureticpeptideisapowerfulpredictorofoutcomeinstrokepatientswithatrialfibrillation